🇺🇸 FDA
Pipeline program

Biomarker

ASF/001-01

Approved gene_therapy terminated

Quick answer

Biomarker for Transplantation, Liver is a Approved program (gene_therapy) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Transplantation, Liver
Phase
Approved
Modality
gene_therapy
Status
terminated

Clinical trials